MedTrace Logo

Design of the EFECTS Trial

NCT02017366 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-12-06

No results posted yet for this study

Summary

It is well known that there is a considerable postoperative weight loss in patients undergoing esophageal resection for cancer.

We believe that this weigh loss can be limited by administering postoperative enteral feeding (target: 1000 kCal/ day) via feeding jejunostomy for at least 6 weeks postoperatively.

We hypothesize that patients undergoing esophageal resection for cancer will have a better overall survival with postoperative additional enteral feeding than when on regular oral diet alone.

Conditions

  • Esophageal Cancer

Interventions

OTHER

Enteral feeding

Target of 1000 kCal/day enteral feeding or glucose 20%, perferably given overnight.

Sponsors & Collaborators

  • University Hospital, Gasthuisberg

    lead OTHER

Principal Investigators

  • Hans Van Veer, MD · Universitaire Ziekenhuizen KU Leuven

  • Philippe Nafteux, MD · Universitaire Ziekenhuizen KU Leuven

  • Willy Coosemans, MD, PhD · Universitaire Ziekenhuizen KU Leuven

  • Johnny Moons, MScN · Universitaire Ziekenhuizen KU Leuven

  • Paul De Leyn, MD, PhD · Universitaire Ziekenhuizen KU Leuven

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-31
Primary Completion
2021-10-31
Completion
2022-04-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02017366 on ClinicalTrials.gov